Studies on formulation development of a poorly water-soluble drug through solid dispersion technique

Thai Journal of Pharmaceutical Sciences

Volumn 34, Issue 2, 2010, Pages 77-87

  Dahiya, Sunita ^a  

^a Nri Institute Of Pharamcy Bhopal   (India)

Author keywords

Aceclofenac; BCS class II; Dissolution enhancement; Poorly water soluble drug; Solid dispersion; Water soluble carriers

Indexed keywords

ACECLOFENAC; BETA CYCLODEXTRIN; DRUG CARRIER; MACROGOL 6000;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; SCANNING ELECTRON MICROSCOPY; SOLVENT EFFECT; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS;

EID: 77956259504     PISSN: 01254685     EISSN: 19054637     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. S. C. Sweetman. Martindale: The Complete Drug Reference, The Pharmaceutical Press, Great Britain, 2002, pp. 11.
2. B. N. Suhagia, H. M. Patel, S. A. Shah, I. Rathod, and V. K. Parmar. Preparation and characterization of etoricoxibpolyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions, Acta Pharm. 56: 285-298 (2006).
3. A. T. M. Serajuddin. Solid dispersions of poorly water soluble drugs: early promises, susbsequent problems and recent breakthroughs, J. Pharm. Sci. 88: 1058-1086 (1999).
4. A. T. M. Serajuddin, P. C. Sheen, and Augustine M. A. Improved dissolution of a poorly water-soluble drugs from solid dispersion in polyethylene glycol:polysorbate 80 mixtures, J. Pharm. Sci. 79: 463-464 (1990).
5. G. V. Betageri, and K. R. Makarla. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques, Int. J. Pharm. 126: 155-160 (1995).
6. S. Chutimaworapan, G. C. Ritthidej, E. Yonemochi, T. K. Oguchi, and T. Yamamoto. Effect of water soluble carriers on dissolution characteristics of nifedipine solid dispersions, Drug Dev. Ind. Pharm. 26: 1141-1150 (2000).
7. M. Fernandez, I. C. Rodriguez, M. V. Margarit, and A. Cerezo. Characterization of solid dispersions of piroxicam/poly (ethylene glycol) 4000, Int. J. Pharm. 84: 197-202 (1992).
8. United States Pharmacopoeia, 27, NF 18, The USP Convention, Rockville 1995, pp. 2303-2304.
9. R. Christoher, and N. Eleftheria. Analysis of dissolution data. In: J. B. Dressman, and H. Lennernas (eds), Oral Drug Absortion: Prediction and Assessment, Marcel Dekker, New York, 2000, pp. 241-242.
10. [] FDA Center for Drug Evaluation and Research. Guidance for Industry: Immediate Release Solid Oral Dosage Forms - Scale-up and Post-Approval Changes: Chemistry, Manufacturing and Controls, In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation (SUPAC-IR), FDA, Rockville, MD, November 1995.
11. C. Leuner, and Dressman J. Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. Biopharm. 50: 47-60 (2000).
12. D. Q. M. Craig. The mechanism of solid dispersions in water soluble polymers, Int. J. Pharm. 231: 131-144 (2002).
13. FDA Center for Drug Evaluation and Research. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, FDA, Rockville, MD, August 1997.